TVGNW Tevogen Bio Holdings Inc. - Warrant
$0.05
가격 · 8월 17, 2026
기준 재무 정보 8월 14, 2026
TVGNW 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$0.05
시가총액
—
P/E (TTM)
-0.0
EPS (TTM)
$-8.08
매출 (TTM)
—
배당 수익률
—
ROE
—
부채/자본
—
52주 범위
$0 – $0
TVGNW 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
EPS
$-8.08
2023-12-31
→
2025-12-31
잉여현금흐름
—
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
TVGNW
동종업계 중앙값
P/E (TTM)
-0.0
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
TVGNW
동종업계 중앙값
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
TVGNW
동종업계 중앙값
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
TVGNW
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
TVGNW
동종업계 중앙값
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $11M | $31M | $4M | · | |
| SG&A Expense | $15M | $23M | $4M | $953.1K | |
| Operating Expenses | $26M | $54M | $9M | $953.1K | |
| Operating Income | $-26M | $-54M | $-9M | · | |
| Interest Expense | · | $184.0K | $1M | · | |
| Interest Income | · | · | $3M | $5M | |
| Other Non-op | · | · | $2M | $5M | |
| Income Tax | $4.8K | $1.8K | · | · | |
| Net Income | $-26M | $-14M | $-60M | $4M | |
| EPS (Basic) | $-8.08 | $-3.50 | $-2.44 | · | |
| EPS (Diluted) | $-8.08 | $-3.50 | $-2.44 | · | |
| Shares (Basic) | 3,319,812 | 2,933,451 | 24,752,000 | · | |
| Shares (Diluted) | 3,319,812 | 2,933,451 | 24,752,000 | · | |
| EBITDA | · | $-54M | · | · |
대차대조표 21
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $552.4K | $0 | $0 | $129.2K | |
| Prepaid Expense | $828.6K | $919.1K | $670.6K | $145.2K | |
| Current Assets | $2M | $2M | $2M | $274.4K | |
| PP&E (Net) | $170.3K | $296.4K | $458.7K | · | |
| PP&E (Gross) | $584.8K | $721.8K | $721.8K | · | |
| Accum. Depreciation | $414.5K | $425.3K | $263.1K | · | |
| Other Non-current Assets | $1M | $575.8K | $271.1K | · | |
| Total Assets | $4M | $3M | $6M | $357M | |
| Accounts Payable | $3M | $5M | $3M | $210.5K | |
| Accrued Liabilities | $1M | $2M | $1M | · | |
| Short-term Debt | $2M | $2M | · | $0 | |
| Current Liabilities | $7M | $9M | $85M | $350.5K | |
| Capital Leases | $1M | $5.8K | $234.9K | · | |
| Total Liabilities | $13M | $10M | $100M | $15M | |
| Total Debt | · | $2M | · | · | |
| Common Stock | $402 | $356 | $12.0K | · | |
| Paid-in Capital | $123M | $98M | $5M | · | |
| Retained Earnings | $-140M | $-113M | $-100M | $-15M | |
| Stockholders' Equity | $-8M | $-7M | $-94M | $-34M | |
| Liabilities + Equity | $4M | $3M | $6M | $357M | |
| Shares Outstanding | 4,020,746 | 3,559,827 | 119,999,989 | 2,383,053 |
현금 흐름 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $16M | $41M | · | · | |
| Operating Cash Flow | $-12M | $-12M | $-8M | $-215.4K | |
| CapEx | $64.4K | · | $133.0K | · | |
| Investing Cash Flow | $-64.4K | · | $-133.0K | · | |
| Stock Repurchased | · | · | $343M | · | |
| Net Stock Activity | · | · | $-343M | · | |
| Financing Cash Flow | $12M | $12M | $4M | · | |
| Net Change in Cash | $-730.6K | $230.6K | $-4M | · |
수익성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | · | -306.2% | -0.04% | 1.2% | |
| ROE | · | 213.4% | 0.12% | -29.9% |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | 0.3 | 0.1 | 0.8 | |
| Quick Ratio | · | 0.0 | 0.0 | 0.4 | |
| Debt / Equity | · | -0.2 | · | · | |
| Interest Coverage | · | -291.1 | · | · |
가치 평가 (TTM) 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $-195.6K | $-184.0K | · | · | |
| Net Income TTM | $-26M | $-14M | $-60M | $4M | |
| P/E | -0.0 | · | · | · | |
| Earnings Yield | -18198.2% | · | · | · |
손익계산서 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $21M | $908.0K | $1M | $1M | $1M | · | · | |
| SG&A Expense | $2M | $2M | $3M | $3M | $3M | $7M | $7M | $3M | $4M | $9M | $1M | $1M | $1M | $977.1K | $198.8K | $258.6K | |
| Operating Expenses | $6M | $5M | $5M | $6M | $5M | $10M | $9M | $6M | $9M | $30M | $2M | $2M | $2M | $2M | $198.8K | $258.6K | |
| Operating Income | $-6M | $-5M | $-5M | $-6M | $-5M | $-10M | $-9M | $-6M | $-9M | $-30M | $-2M | $-2M | $-2M | $-2M | · | · | |
| Interest Expense | · | · | · | · | · | $24.6K | · | $12.5K | · | $155.8K | $317.5K | $299.9K | · | $289.0K | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $300.0K | $300.0K | $2M | $2M | $-125.1K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | $327.2K | $331.5K | $2M | $2M | $465.6K | |
| Net Income | $-6M | $-5M | $-5M | $-6M | $-6M | $-10M | $-9M | $-6M | $-10M | $11M | $-4M | $-4M | $-22M | $-31M | $2M | $207.0K | |
| EPS (Basic) | $-1.52 | $-1.61 | $-7.95 | $-0.03 | $-1.71 | $-3.25 | $-3.51 | $-0.03 | $-0.04 | $0.08 | $-1.97 | $-0.03 | $-0.18 | $-0.26 | · | · | |
| EPS (Diluted) | $-1.52 | $-1.61 | $-7.95 | $-0.03 | $-1.71 | $-3.25 | $-3.17 | $-0.03 | $-0.04 | $-0.26 | $-1.97 | $-0.03 | $-0.18 | $-0.26 | · | · | |
| Shares (Basic) | 3,829,365 | 3,486,215 | -538,423,264 | 196,028,784 | 3,293,065 | 3,228,142 | -458,741,974 | 170,174,533 | 154,167,090 | 137,333,802 | -335,247,967 | 119,999,989 | 119,999,989 | 119,999,989 | · | · | |
| Shares (Diluted) | 3,829,365 | 3,486,215 | -538,423,264 | 196,028,784 | 3,293,065 | 3,228,142 | -463,795,823 | 170,174,533 | 154,167,090 | 142,387,651 | -335,247,967 | 119,999,989 | 119,999,989 | 119,999,989 | · | · | |
| EBITDA | $-6M | $-5M | · | $-6M | $-5M | $-10M | · | $-6M | $-9M | $-30M | · | · | · | · | · | · |
대차대조표 21
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $692.3K | $0 | $1M | $685.2K | $2M | $0 | $2M | $1M | $1M | $0 | $25M | $25M | $52.3K | $143.0K | $185.6K | |
| Prepaid Expense | $768.3K | $1M | $828.6K | $925.8K | $1M | $944.1K | $919.1K | $1M | $1M | $923.2K | $670.6K | $51.9K | $143.3K | $44.8K | $275.4K | $409.1K | |
| Current Assets | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $4M | $2M | $2M | $2M | $399.5K | $699.3K | $97.1K | $418.5K | $594.8K | |
| PP&E (Net) | $109.8K | $140.0K | $170.3K | $163.9K | $164.4K | $255.9K | $296.4K | $337.0K | $377.5K | $418.1K | $458.7K | · | · | · | · | · | |
| PP&E (Gross) | · | · | $584.8K | · | · | · | $721.8K | · | · | · | $721.8K | · | · | · | · | · | |
| Accum. Depreciation | · | · | $414.5K | · | · | · | $425.3K | · | · | · | $263.1K | · | · | · | · | · | |
| Other Non-current Assets | $1M | $1M | $1M | $565.9K | $565.9K | $575.8K | $575.8K | $133.3K | $133.3K | $133.3K | $271.1K | · | · | · | · | · | |
| Total Assets | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $6M | $26M | $26M | $25M | $355M | $353M | |
| Accounts Payable | $3M | $4M | $3M | $3M | $4M | $5M | $5M | $6M | $7M | $5M | $3M | $1M | $694.9K | $485.1K | $171.8K | $179.2K | |
| Accrued Liabilities | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | · | · | · | · | · | |
| Short-term Debt | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $625.7K | $625.7K | · | · | · | |
| Current Liabilities | $6M | $7M | $7M | $7M | $8M | $9M | $9M | $10M | $11M | $9M | $85M | $2M | $2M | $667.1K | $281.8K | $259.2K | |
| Capital Leases | $1M | $1M | $1M | $1M | $1M | · | $5.8K | $42.6K | $96.8K | $166.8K | $234.9K | · | · | · | · | · | |
| Total Liabilities | $14M | $15M | $13M | $12M | $14M | $12M | $10M | $10M | $11M | $9M | $100M | $17M | $16M | $15M | $15M | $15M | |
| Total Debt | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $625.7K | · | · | · | · | |
| Common Stock | $426 | $417 | $402 | $19.7K | $19.4K | $18.4K | $356 | $17.1K | $16.9K | $16.5K | $12.0K | · | · | · | · | · | |
| Paid-in Capital | $133M | $126M | $123M | $118M | $111M | $107M | $98M | $91M | $88M | $76M | $5M | · | · | · | · | · | |
| Retained Earnings | $-151M | $-145M | $-140M | $-135M | $-129M | $-124M | $-113M | $-104M | $-98M | $-88M | $-100M | $-16M | $-16M | $-15M | $-15M | $-14M | |
| Stockholders' Equity | $-9M | $-10M | $-8M | $-8M | $-9M | $-8M | $-7M | $-6M | $-8M | $-6M | $-94M | $-16M | $-16M | $-15M | $-15M | $-14M | |
| Liabilities + Equity | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $6M | $26M | $26M | $25M | $355M | $353M | |
| Shares Outstanding | 4,255,107 | 4,168,705 | 4,020,746 | 197,391,411 | 193,693,433 | 183,893,433 | 3,559,827 | 170,773,864 | 168,826,402 | 164,614,418 | 119,999,989 | · | · | · | · | · |
현금 흐름 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $3M | $2M | $3M | $3M | $7M | $7M | $3M | $4M | $26M | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-2M | $-4M | $-3M | $-3M | $-3M | $-4M | $-3M | $-2M | $-2M | $-6M | $-4M | $-2M | $-42.6K | $-45.9K | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $133.0K | · | · | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | $-333M | $-333M | $-133.0K | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $3M | $3M | $2M | $4M | $2M | $4M | $2M | $5M | $3M | $2M | $422.2K | $336M | $336M | $2M | · | · | |
| Net Change in Cash | $389.9K | $139.9K | $-484.7K | $351.9K | $-1M | $691.9K | $-1M | $1M | $-182.5K | $265.5K | $-2M | $-850.0K | · | · | · | · |
수익성 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 5755.2% | 7589.2% | · | 9190.6% | 14315.3% | · | · | · | -143317116.7% | · | · | · | · | · | · | · | |
| Net Margin | 5856.4% | 7652.9% | · | 9186.4% | 14471.6% | · | · | · | -161057450.0% | · | · | · | · | · | · | · | |
| EBITDA Margin | 5755.2% | 7589.2% | · | 9190.6% | 14315.3% | · | · | · | -143317116.7% | · | · | · | · | · | · | · | |
| ROA | -128.1% | -121.1% | · | -130.4% | -145.2% | -278.8% | · | -38.3% | -65.1% | 78.1% | · | -0.15% | · | 0.65% | 0.91% | 0.12% | |
| ROE | 62.7% | 62.0% | · | 81.7% | 64.3% | 153.3% | · | 52.6% | 83.4% | -106.6% | · | 1.8% | · | -8.3% | -22.0% | -2.9% |
유동성 및 지급능력 4
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.2 | 0.3 | · | 0.2 | · | 0.1 | 1.5 | 2.3 | |
| Quick Ratio | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 13.7 | · | 0.1 | 0.5 | 0.7 | |
| Debt / Equity | -0.2 | -0.2 | · | -0.2 | -0.2 | -0.2 | · | -0.3 | -0.2 | -0.3 | · | -0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | -421.5 | · | -488.4 | · | -189.5 | · | · | · | · | · | · |
효율성 1
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | -0.0 | -0.0 | · | -0.0 | -0.0 | · | · | · | 0.0 | · | · | · | · | · | · | · |
가치 평가 (TTM) 11
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $-269.9K | $-196.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-22M | $-27M | · | $-27M | $-31M | $-15M | · | $-8M | $-24M | $-46M | · | $-55M | $-51M | $-29M | $2M | $169.6K | |
| Market Cap | $144.2K | $141.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | $713.1K | $1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | -0.5 | -0.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | -0.1 | -0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | -2.6 | -5.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -14365.8% | -14513.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 순이익 | $-26M | $-14M | $-60M | $4M | — |
| 희석 EPS | $-8.08 | $-3.50 | $-2.44 | — | — |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | — | -0.2 | — | — | — |
| 유동비율 | — | 0.3 | 0.1 | 0.8 | 13.3 |
| 당좌 비율 | — | 0.0 | 0.0 | 0.4 | 5.8 |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 36개의 제출자 · $8.9M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 3 (-1 이전 분기 대비) | 2 (+1 이전 분기 대비) | 2 (-1 이전 분기 대비) | 1 (-1 이전 분기 대비) | +1.1M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Saadi Ryan H. | 2026년 7월 14일 | 59.70% | 수정본 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.